News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,193 Results
Type
Article (42578)
Company Profile (438)
Press Release (676176)
Multimedia
Podcasts (83)
Webinars (14)
Section
Business (208846)
Career Advice (2024)
Deals (36031)
Drug Delivery (104)
Drug Development (83652)
Employer Resources (173)
FDA (16481)
Job Trends (15120)
News (353042)
Policy (33123)
Tag
Academia (2647)
Accelerated approval (7)
Adcomms (26)
Allergies (94)
Alliances (51066)
ALS (107)
Alzheimer's disease (1464)
Antibody-drug conjugate (ADC) (165)
Approvals (16458)
Artificial intelligence (305)
Autoimmune disease (30)
Automation (18)
Bankruptcy (373)
Best Places to Work (11841)
BIOSECURE Act (19)
Biosimilars (111)
Biotechnology (331)
Bladder cancer (93)
Brain cancer (32)
Breast cancer (357)
Cancer (2762)
Cardiovascular disease (212)
Career advice (1692)
Career pathing (30)
CAR-T (185)
CDC (27)
Cell therapy (501)
Cervical cancer (21)
Clinical research (68378)
Collaboration (994)
Company closure (3)
Compensation (637)
Complete response letters (24)
COVID-19 (2674)
CRISPR (61)
C-suite (301)
Cystic fibrosis (114)
Data (2822)
Decentralized trials (2)
Denatured (29)
Depression (60)
Diabetes (305)
Diagnostics (6466)
Digital health (22)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (137)
Drug pricing (125)
Drug shortages (28)
Duchenne muscular dystrophy (121)
Earnings (88611)
Editorial (44)
Employer branding (21)
Employer resources (148)
Events (117142)
Executive appointments (842)
FDA (18017)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (896)
Gene editing (135)
Generative AI (22)
Gene therapy (384)
GLP-1 (788)
Government (4556)
Grass and pollen (4)
Guidances (179)
Healthcare (19168)
Huntington's disease (29)
IgA nephropathy (38)
Immunology and inflammation (151)
Immuno-oncology (6)
Indications (36)
Infectious disease (2830)
Inflammatory bowel disease (153)
Inflation Reduction Act (12)
Influenza (57)
Intellectual property (111)
Interviews (312)
IPO (16853)
IRA (45)
Job creations (3706)
Job search strategy (1435)
Kidney cancer (13)
Labor market (49)
Layoffs (516)
Leadership (18)
Legal (7996)
Liver cancer (78)
Lung cancer (393)
Lymphoma (196)
Machine learning (9)
Management (58)
Manufacturing (365)
MASH (87)
Medical device (13575)
Medtech (13580)
Mergers & acquisitions (19838)
Metabolic disorders (804)
Multiple sclerosis (96)
NASH (19)
Neurodegenerative disease (122)
Neuropsychiatric disorders (36)
Neuroscience (2135)
NextGen: Class of 2025 (6761)
Non-profit (4555)
Now hiring (45)
Obesity (423)
Opinion (232)
Ovarian cancer (95)
Pain (106)
Pancreatic cancer (108)
Parkinson's disease (183)
Partnered (22)
Patents (279)
Patient recruitment (139)
Peanut (49)
People (58958)
Pharmaceutical (86)
Pharmacy benefit managers (21)
Phase I (21506)
Phase II (30177)
Phase III (22287)
Pipeline (1568)
Policy (186)
Postmarket research (2601)
Preclinical (9233)
Press Release (67)
Prostate cancer (134)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (460)
Real estate (6020)
Recruiting (66)
Regulatory (22939)
Reports (50)
Research institute (2419)
Resumes & cover letters (352)
Rett syndrome (9)
RNA editing (9)
RSV (45)
Schizophrenia (87)
Series A (155)
Series B (103)
Service/supplier (11)
Sickle cell disease (63)
Special edition (21)
Spinal muscular atrophy (152)
Sponsored (32)
Startups (3769)
State (2)
Stomach cancer (14)
Supply chain (72)
Tariffs (55)
The Weekly (52)
Vaccines (761)
Venture capitalists (49)
Weight loss (266)
Women's health (43)
Worklife (17)
Date
Today (146)
Last 7 days (516)
Last 30 days (2483)
Last 365 days (32732)
2025 (15413)
2024 (36304)
2023 (41016)
2022 (52277)
2021 (56763)
2020 (54921)
2019 (47421)
2018 (35699)
2017 (33029)
2016 (32349)
2015 (38400)
2014 (32187)
2013 (27112)
2012 (29222)
2011 (29867)
2010 (27995)
Location
Africa (738)
Alabama (64)
Alaska (7)
Arizona (249)
Arkansas (14)
Asia (39531)
Australia (6566)
California (7250)
Canada (2262)
China (646)
Colorado (308)
Connecticut (321)
Delaware (183)
Europe (86494)
Florida (1071)
Georgia (238)
Idaho (58)
Illinois (627)
India (26)
Indiana (350)
Iowa (18)
Japan (213)
Kansas (111)
Kentucky (28)
Louisiana (14)
Maine (64)
Maryland (1008)
Massachusetts (5476)
Michigan (240)
Minnesota (437)
Mississippi (3)
Missouri (86)
Montana (30)
Nebraska (25)
Nevada (77)
New Hampshire (69)
New Jersey (2013)
New Mexico (30)
New York (2022)
North Carolina (1113)
North Dakota (9)
Northern California (3170)
Ohio (230)
Oklahoma (15)
Oregon (38)
Pennsylvania (1559)
Puerto Rico (16)
Rhode Island (37)
South America (1112)
South Carolina (32)
South Dakota (1)
Southern California (2695)
Tennessee (118)
Texas (1072)
United States (26990)
Utah (213)
Virginia (177)
Washington D.C. (73)
Washington State (627)
West Virginia (4)
Wisconsin (66)
719,193 Results for "curie therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Secarna Pharmaceuticals and Curie.Bio Portfolio Company Enter into Research and Option Agreement
May 12, 2025
·
3 min read
Press Releases
Curis Provides First Quarter 2025 Business Update
May 7, 2025
·
12 min read
Press Releases
Curi Bio and Cook MyoSite Announce Strategic Partnership
April 30, 2025
·
3 min read
Business
Curie.Bio Adds $380M Series A Fund to Move Biotech Startups to Clinic
The biotech incubator said Wednesday the majority of the fund will be for clinical proof-of-concept studies, bringing the total funds raised by Curie.Bio to nearly $1 billion.
June 26, 2024
·
1 min read
·
Kate Goodwin
Press Releases
Curis to Present at Upcoming Healthcare Conference in April 2025
April 3, 2025
·
1 min read
Press Releases
Curis Provides Fourth Quarter 2024 Business Update
April 1, 2025
·
14 min read
Press Releases
Curis to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2025
April 30, 2025
·
1 min read
Genetown
Curie.Bio Raises $380M Pro Rata Series A Fund To Support Portfolio Companies Through Clinical Trials
We’re excited to announce today that we have closed $380 million for our latest fund, bringing the total funds raised by Curie.Bio to nearly $1 billion.
June 26, 2024
·
4 min read
Genetown
Curis to Present at Upcoming Healthcare Conferences in April
Curis, Inc. today announced that James Dentzer , President and Chief Executive Officer of Curis, will participate at the 23rd Annual Needham Virtual Healthcare Conference being held on April 8 - 11, 2024.
April 4, 2024
·
1 min read
Genetown
Curis to Present Updated Data from the TakeAim Leukemia Study
Curis, Inc. announced that the Company will present updated data from the TakeAim Leukemia study Tuesday, May 14, 2024, at 4:00 p.m. ET.
May 10, 2024
·
1 min read
1 of 71,920
Next
